NASDAQ:OVID | Free Cash Flow | Ovid Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$13.9M
2025-12-31-$10.41M$0.00-$10.41M-107.71%
2025-03-31-$10.28M$0.00-$10.28M
2024-12-31-$10.01M$22,000.00-$10.03M
2024-03-31-$16.69M$19,000.00-$16.71M
2023-12-31-$11.91M$13,000.00-$11.92M
2023-03-31-$12.11M$14,000.00-$12.13M
2022-12-31-$9.18M$119,939.00-$9.3M
2022-03-31-$20.09M$45,935.00-$20.13M
2021-12-31-$12M$161,958.00-$12.16M
2021-03-31$160.9M$11,514.00$160.89M91.41%
2020-12-31-$14.51M$41,883.00-$14.55M
2020-03-31-$18.41M$14,139.00-$18.43M
2019-12-31-$16.89M$31,245.00-$16.92M
2019-03-31-$12.87M$4,324.00-$12.87M
2018-12-31-$10.97M-$5,621.00-$10.97M
2018-03-31-$12.93M$7,581.00-$12.93M
2017-12-31-$9.01M$7,802.00-$9.01M
2017-03-31-$7.16M$12,131.00-$7.17M
2016-12-31-$5.71M$3,426.00-$5.72M
2016-03-31-$3.84M$14,653.00-$3.86M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$38.33M$0.00-$38.33M
2024-12-31-$55.96M$71,000.00-$56.03M
2023-12-31-$45.78M$40,000.00-$45.82M
2022-12-31-$55.23M$1.22M-$56.45M
2021-12-31$118.61M$184,008.00$118.43M96.41%
2020-12-31-$51.58M$127,240.00-$51.71M
2019-12-31-$51.09M$57,156.00-$51.15M
2018-12-31-$45.56M$33,871.00-$45.59M
2017-12-31-$31.47M$38,907.00-$31.51M
2016-12-31-$17.8M$30,364.00-$17.83M
2015-12-31-$5.49M$32,082.00-$5.52M